Sign Up Now For
HEALTHbeat
Our FREE E-mail Newsletter

In each issue of HEALTHbeat:

  • Get trusted advice from the doctors at Harvard Medical School
  • Learn tips for living a healthy lifestyle
  • Stay up-to-date on the latest developments in health
  • Receive special offers on health books and reports
  • Plus, receive your FREE Bonus Report, Living to 100: What's the secret?

[ Maybe Later ] [ No Thanks ]

Check out these newly released Special Health Reports from Harvard Medical School
Learn How

New Releases

You can't buy good health but you can buy good health information. Check out these newly released Special Health Reports from Harvard Medical School:

New osteoarthritis treatments on the horizon, from the May 2013 Harvard Women's Health Watch

For years, osteoarthritis treatments have focused on relieving symptoms: nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen to control pain, steroid injections to bring down inflammation, and viscosupplements to replace a joint's natural lubricant. The May 2013 Harvard Women's Health Watch looks at some on-the-horizon therapies that could change the way this degenerative disease is treated.

"We're beginning to understand that osteoarthritis is a disease of the entire joint," explains Dr. Antonios Aliprantis, director of the Osteoarthritis Center at Harvard-affiliated Brigham and Women's Hospital. "Much of the research over the last 20 or 30 years has focused on cartilage as the target. But we're beginning to realize that there are important changes happening in the bone underneath the cartilage, and in the joint lining itself. As we begin to understand osteoarthritis as a disease of the entire joint, new treatment targets will emerge."

One treatment in development is a drug called strontium ranelate, which has been used in Europe to treat osteoporosis-related bone loss. It's now finding a new purpose for knee osteoarthritis. Strontium appears to inhibit the activity of cells called osteoclasts, which break down bone. It is possible that in a joint affected by osteoarthritis, strontium ranelate may protect bone under the cartilage.

Stem cells, which are able to transform into many different types of cells, also show potential for treating osteoarthritis. The hope is that injecting stem cells into damaged joints might regenerate healthy tissue.

Osteoarthritisis is a localized disease, so the ideal treatment would be injected directly into the joint. That would avoid the body-wide side effects of current osteoarthritis drugs. Dr. Aliprantis envisions a medication embedded in a gel-like substance that would release the drug slowly into the joint, as it's needed, to repair damaged tissue, "sort of like an on-demand system," he says.

While it may take time for these new therapies to come to fruition, there are several options that can help relieve osteoarthritis pain and stiffness, including:

  • oral pain medications such as acetaminophen and NSAIDs (ibuprofen, naproxen)
  • topical pain-relieving creams and rubs applied to the skin over the painful joint
  • hyaluronic acid injections (viscosupplements) to replace the fluid that naturally lubricates the joint

Read the full-length article: "New ways to beat osteoarthritis pain"

Also in this issue of the Harvard Women's Health Watch

  • New ways to beat osteoarthritis pain
  • Ask the doctor: Will lifestyle changes help with systolic hypertension?
  • Ask the doctor: Do I need hemorrhoid surgery?
  • Avoiding dangerous drug interactions
  • What you can do about incontinence
  • Why the Mediterranean diet is so good for your heart
  • Research We're Watching: Tai chi prevents falls after a stroke
  • Research We're Watching: Calcium could harm women's hearts
  • Research We're Watching: Older women can wait two years for next mammogram
  • Research We're Watching: Mindfulness meditation for arthritis

More Harvard Health News »


About Harvard Health Publications

Harvard Health Publications publishes four monthly newsletters--Harvard Health Letter, Harvard Women's Health Watch, Harvard Men's Health Watch, and Harvard Heart Letter--as well as more than 50 special health reports and books drawing on the expertise of the 8,000 faculty physicians at Harvard Medical School and its world-famous affiliated hospitals.